{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:59:20Z","timestamp":1648785560738},"reference-count":12,"publisher":"Japanese Urological Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5980\/jpnjurol.103.610","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T23:30:23Z","timestamp":1378164623000},"page":"610-616","source":"Crossref","is-referenced-by-count":0,"title":["THE INTRAVESICAL RECURRENCE AFTER 3-DAY CONSECUTIVE INTRAVESICAL INSTILLATION OF PIRARUBICINE HYDROCHLORIDE (THP) FOLLOWING TRANSURETHRAL RESECTION OF BLADDER TUMOR (TURBT) FOR NON-MUSCLE-INVASIVE BLADDER CANCER"],"prefix":"10.5980","volume":"103","author":[{"given":"Tatsuo","family":"Tochigi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadafumi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigemi","family":"Itou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikurou","family":"Satou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., B\u00f6hle A. and Palou-Redorta J.: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur. Urol., 54, 303-314, 2008.","DOI":"10.1016\/j.eururo.2008.04.051"},{"key":"2"},{"key":"3"},{"key":"4"},{"key":"5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sylvester R.J., Oosterlinck W. and van der Meijden A.P.M.: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials. J. Urol., 171, 2186-2190, 2004.","DOI":"10.1097\/01.ju.0000125486.92260.b2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Sylvester R.J., Oosterlinck W. and Witjes J.A.: The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: A systematic review of the published results of randomized clinical trials. Eur. Urol., 53, 709-719, 2008.","DOI":"10.1016\/j.eururo.2008.01.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hinotsu S., Akaza H., Ohashi Y. and Kotake T.: Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection. Cancer, 86, 1818-1826, 1999.","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1818::AID-CNCR25>3.0.CO;2-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Okamura K., Ono Y., Kinukawa T., Matsuura O., Yamada S., Ando T., Fukatsu T., Ohno Y. and Ohshima S.; members of Nagoya University Urological Oncology Group: Randomized study of single early instillation of (2&apos;&apos;R) -4&apos;-0-tetrahydropyranyl-doxorubicine for a single superficial bladder carcinoma. Cancer, 94, 2363-2368, 2002.","DOI":"10.1002\/cncr.10496"},{"key":"10"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Koga H., Kuroiwa K., Yamaguchi A., Osada Y., Tsuneyosi M. and Naito S.: A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of TA\/T1 transitional cell carcinoma of the bladder. J. urol., 171, 153-157, 2004.","DOI":"10.1097\/01.ju.0000100386.07370.0a"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sylvester R.J., Brausi M.A., Kirkels W.J, Hoeltl W., Da Silva F.C., Powell P.H., Prescott S., Kirkali Z., van de Beek C., Gorlia T. and de Reijke T.M.: Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, Bacillus Calmette-Gu\u00e9rin, and Bacillus Calmette-Gu\u00e9rin plus isoniazid in patients with intermediate-and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur. Urol., 57, 766-773, 2010.","DOI":"10.1016\/j.eururo.2009.12.024"}],"container-title":["The Japanese Journal of Urology"],"original-title":["\u7b4b\u5c64\u975e\u6d78\u6f64\u6027\u8180\u80f1\u764c\u306b\u304a\u3051\u308b\u7d4c\u5c3f\u9053\u7684\u8180\u80f1\u816b\u760d\u5207\u9664\u8853\uff08TURBT\uff09\u5f8c\u5869\u9178\u30d4\u30e9\u30eb\u30d3\u30b7\u30f3\uff08THP\uff093\u65e5\u9593\u9023\u7d9a\u8180\u80f1\u5185\u6ce8\u5165\u7642\u6cd5\u306e\u8180\u80f1\u5185\u518d\u767a\u306b\u95a2\u3059\u308b\u691c\u8a0e"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T22:27:29Z","timestamp":1621549649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/103\/4\/103_610\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.103.610","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}